Genertec Universal Medical Group Company Limited (FRA:5UM)

FRA:5UM Statistics

Total Valuation

FRA:5UM has a market cap or net worth of EUR 1.40 billion.

Market Cap	1.40B
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	Jun 12, 2025

Share Statistics

Current Share Class	2.01B
Shares Outstanding	n/a
Shares Change (YoY)	-2.00%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	0.38%
Owned by Institutions (%)	22.31%
Float	1.24B

Valuation Ratios

The trailing PE ratio is 5.54 and the forward PE ratio is 5.31.

PE Ratio	5.54
Forward PE	5.31
PS Ratio	0.82
PB Ratio	0.52
P/TBV Ratio	0.65
P/FCF Ratio	2.56
P/OCF Ratio	2.10
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.68, with a Debt / Equity ratio of 2.28.

Current Ratio	2.68
Quick Ratio	2.60
Debt / Equity	2.28
Debt / EBITDA	n/a
Debt / FCF	11.33
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.38%.

Return on Equity (ROE)	10.38%
Return on Assets (ROA)	2.76%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	75,578
Profits Per Employee	11,156
Employee Count	22,885
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:5UM has paid 81.82 million in taxes.

Income Tax	81.82M
Effective Tax Rate	22.72%

Stock Price Statistics

The stock price has increased by +31.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.37%
50-Day Moving Average	0.67
200-Day Moving Average	0.62
Relative Strength Index (RSI)	47.19
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:5UM had revenue of EUR 1.71 billion and earned 252.30 million in profits. Earnings per share was 0.13.

Revenue	1.71B
Gross Profit	547.86M
Operating Income	331.51M
Pretax Income	360.12M
Net Income	252.30M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 269.66 million in cash and 6.19 billion in debt, giving a net cash position of -5.92 billion.

Cash & Cash Equivalents	269.66M
Total Debt	6.19B
Net Cash	-5.92B
Net Cash Per Share	n/a
Equity (Book Value)	2.71B
Book Value Per Share	1.18
Working Capital	5.67B

Cash Flow

In the last 12 months, operating cash flow was 664.35 million and capital expenditures -118.50 million, giving a free cash flow of 545.84 million.

Operating Cash Flow	664.35M
Capital Expenditures	-118.50M
Free Cash Flow	545.84M
FCF Per Share	n/a

Margins

Gross margin is 32.05%, with operating and profit margins of 19.40% and 15.23%.

Gross Margin	32.05%
Operating Margin	19.40%
Pretax Margin	21.07%
Profit Margin	15.23%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	31.94%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 5.80%.

Dividend Per Share	0.04
Dividend Yield	5.80%
Dividend Growth (YoY)	-7.04%
Years of Dividend Growth	1
Payout Ratio	55.19%
Buyback Yield	2.00%
Shareholder Yield	7.79%
Earnings Yield	18.06%
FCF Yield	39.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6